Isolation and Characterization of Unknown Impurities in Pharmaceuticals and Chemicals
At Chemicea, we provide comprehensive analytical solutions for the isolation, identification, and characterization of unknown impurities found in pharmaceutical products, active pharmaceutical ingredients (APIs), intermediates, fine chemicals, and specialty chemicals.
Unknown impurities can arise during synthesis, storage, manufacturing, packaging, or degradation processes. Regulatory authorities require thorough investigation and identification of impurities above specified reporting thresholds to ensure product safety, efficacy, and quality.
Our Expertise
Our team of experienced scientists utilizes advanced analytical techniques to isolate, identify, and characterize unknown impurities, degradation products, process-related impurities, and extractables/leachables.
Services Offered
Analytical Techniques Used
We employ a combination of sophisticated analytical instruments to accurately determine impurity structures:
Chromatographic Techniques
Spectroscopic Techniques
Structural Characterization
Our Isolation and Characterization Process
1. Detection of Unknown Impurity
The impurity is detected through routine analysis, stability studies, process development, or quality control testing.
2. Isolation and Enrichment
The impurity is isolated using preparative chromatography techniques to obtain sufficient quantity for characterization.
3. Structural Elucidation
Advanced analytical tools such as LC-MS, HRMS, NMR, and FTIR are used to determine the molecular structure.
4. Confirmation and Reporting
The proposed structure is confirmed through comprehensive data interpretation and documented in a detailed analytical report.
Industries We Serve
Why Choose Chemicea?
✔ Experienced analytical scientists
✔ Advanced instrumentation and laboratory capabilities
✔ Regulatory-compliant documentation
✔ Fast turnaround time
✔ Customized project support
✔ Confidential and secure handling of samples
✔ Cost-effective analytical solutions
Regulatory Importance
Regulatory agencies such as the U.S. Food and Drug Administration and International Council for Harmonisation require identification and qualification of impurities that exceed specified thresholds. Proper impurity characterization helps ensure product quality, patient safety, and regulatory compliance.